Caption Management »

Perspective Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $250k 60k 4.17

More positions owned by Caption Management

Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
United Therapeutics Corporation (UTHR)
Carvana Cl A Call Option (CVNA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Amazon (AMZN)
Blue Owl Capital Com Cl A (OWL)
Electronic Arts Call Option (EA)
Tesla Motors (TSLA)
Take-Two Interactive Software (TTWO)
Spdr Series Trust State Street Spd Call Option (XBI)
UnitedHealth (UNH)
Netflix (NFLX)
Cg Oncology (CGON)
Microsoft Corporation (MSFT)

View all positions for Caption Management

Top funds holding Perspective Therapeutics

TCG Crossover Management
Commodore Capital
Avidity Partners Management
BlackRock
Opaleye Management
Vanguard Capital Management
Millennium Management
Citadel Advisors
Affinity Asset Advisors
State Street Corporation
Balyasny Asset Management
Morgan Stanley
Geode Capital Management
Patient Square Capital
Nicholson Wealth Management Group

View all funds holding Perspective Therapeutics